抗壁细胞抗体与抗内因子抗体和胃癌风险的关联
该研究在芬兰育龄女性队列(FMC)和老年男性队列(ATBC)中开展巢式病例对照分析,分别纳入529对和457对匹配样本。在幽门螺杆菌(H pylori)血清阴性的年轻女性中,抗壁细胞抗体(APCA)阳性与胃癌风险显著相关(OR 5.52,95%CI 3.16-9.64),且胃底和胃体肿瘤关联最强(OR 24.84,95%CI 8.49-72.72);在男性中未见关联。抗内因子抗体阳性率低于2%,与胃癌风险无统计学关联。
要点
- 在H pylori血清阴性女性中,APCA阳性与胃癌风险升高相关(OR 5.52,95%CI 3.16-9.64)。
- 胃底和胃体部位肿瘤与APCA的关联最强(OR 24.84,95%CI 8.49-72.72)。
- 在男性中,APCA阳性与胃癌风险无统计学关联。
核心结论
- 自身抗体阳性可能反映年轻女性亚临床自身免疫性胃炎,且在H pylori血清阴性个体中自身免疫关联更强,支持自身免疫性胃炎替代H pylori作为驱动因素的模型。
研究设计与样本
- 在芬兰育龄女性队列(FMC,出生1938-1989年)和老年男性队列(ATBC研究,出生1916-1939年)中分别开展巢式胃癌病例对照分析,FMC有529对匹配样本,ATBC研究有457对匹配样本。
- FMC和ATBC研究参与者的平均年龄分别为30.5岁和57.5岁,从基线到癌症诊断的中位时间分别为17年和11年。
- 基线血清采用免疫分析法检测抗壁细胞抗体(APCA)、抗内因子抗体和抗H pylori抗体,数据分析于2019年8月至2020年11月进行。
主要发现
- FMC对照组529人中53名女性(10%)APCA血清阳性,ATBC研究对照组457人中35名男性(7.7%)APCA血清阳性;FMC中146名女性(28%)和ATBC研究中329名男性(72%)H pylori血清阳性。
- 在FMC中,APCA血清阳性与H pylori血清阴性女性的胃癌风险显著相关(OR 5.52,95%CI 3.16-9.64),而与H pylori血清阳性女性无显著关联(OR 1.29,95%CI 0.64-2.60;交互作用P=0.002)。
- 在FMC的H pylori血清阴性女性中,APCA与胃底和胃体部位肿瘤的关联最强(OR 24.84,95%CI 8.49-72.72)。
- 在ATBC研究中,APCA血清阳性与H pylori血清阴性男性的胃癌无关联(OR 0.99,95%CI 0.32-3.04),与H pylori血清阳性男性也无关联(OR 1.06,95%CI 0.60-1.88)。
- 在两个队列中,病例和对照的抗内因子抗体血清阳性率均低于2%,且与胃癌风险无统计学关联。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Autoimmune gastritis is an alternative cause of gastric carcinogenesis. This cause may be gaining importance with declining prevalence of chronic Helicobacter pylori infection. OBJECTIVE: To determine the association of prediagnostic autoantibodies to gastric mucosa with gastric cancer (GC) risk. DESIGN, SETTING, AND PARTICIPANTS: This cohort study used nested GC case-control analyses within separate Finnish cohorts of women of reproductive age (Finnish Maternity Cohort [FMC]; born 1938-1989) and older men (Alpha-Tocopherol, Beta-Carotene Cancer Prevention [ATBC] Study; born 1916-1939). There were 529 and 457 matched pairs from the FMC and ATBC Study, respectively, with mean participant ages of 30.5 and 57.5 years and medians of 17 and 11 years from baseline to cancer diagnosis. Data analyses were performed between August 2019 and November 2020. EXPOSURES: Antiparietal cell antibodies (APCAs), anti-intrinsic factor antibodies, and anti-H pylori antibodies were measured in baseline serum using immunoassays. MAIN OUTCOMES AND MEASURES: Autoantibody associations were estimated by odds ratios (ORs) and 95% CIs. RESULTS: Of the 529 control participants in the FMC and 457 control participants in the ATBC Study, 53 (10%) women and 35 (7.7%) men were APCA seropositive, respectively, whereas 146 (28%) women and 329 (72%) men were H pylori seropositive. In the FMC, APCA seropositivity was statistically significantly associated with GC risk among H pylori-seronegative women (OR, 5.52; 95% CI, 3.16-9.64) but not H pylori-seropositive women (OR, 1.29; 95% CI, 0.64-2.60; P for interaction = .002). The APCA association with H pylori seronegativity was strongest for tumors in the fundus and corpus (OR, 24.84; 95% CI, 8.49-72.72). In the ATBC Study, APCA seropositivity was not associated with GC among either H pylori-seronegative men (OR, 0.99; 95% CI, 0.32-3.04) or H pylori-seropositive men (OR, 1.06; 95% CI, 0.60-1.88). In both cohorts, anti-intrinsic factor antibody seroprevalence was less than 2% among cases as well as controls and not statistically associated with GC risk. CONCLUSIONS AND RELEVANCE: Results of this cohort study demonstrate that autoantibody positivity may reflect subclinical autoimmune gastritis in younger women. The findings among young females and corpus subsite align with increasing cancer incidence trends for these groups. Stronger autoimmune associations in H pylori-seronegative individuals support a model of autoimmune gastritis replacing H pylori as the driving factor.
引用
- Song M, Camargo MC, Katki HA, et al. Association of Antiparietal Cell and Anti-Intrinsic Factor Antibodies With Risk of Gastric Cancer. JAMA Oncol. 2022. PMID: 34913949. doi:10.1001/jamaoncol.2021.5395
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。